The two companies’ applications for China-approved PD-1 inhibitor camrelizumab and the VEGFR tyrosine kinase inhibitor ...

AbbVie is asking the U.S. Supreme Court to overrule a lower court’s ruling that the company must turn over records of ...

Freshly equipped with two approved meds from Acorda Therapeutics, Frankfurt, Germany’s Merz Therapeutics is kicking its ...

Following this month's FDA approval of Eli Lilly’s amyloid-busting antibody Kisunla (donanemab), the Alzheimer’s disease ...

The dog days of summer might be in full swing, but for flu vaccine makers, its a busy time prepping for this fall's influenza ...

After a rocky road to approval and two amendments to the original pact, Akebia Therapeutics and CSL Vifor have terminated ...